USD 0.16
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.9 Million GBP | -10.0% |
2022 | 4.33 Million GBP | 138.93% |
2021 | 1.81 Million GBP | 95.69% |
2020 | 928 Thousand GBP | -22.73% |
2019 | 1.2 Million GBP | 0.0% |
2018 | - GBP | 0.0% |
2017 | - GBP | 0.0% |
2016 | - GBP | 0.0% |
2015 | - GBP | 0.0% |
2014 | - GBP | 0.0% |
2013 | - GBP | -100.0% |
2012 | 131.75 Thousand GBP | 0.57% |
2011 | 131 Thousand GBP | -40.99% |
2010 | 222 Thousand GBP | 126.53% |
2009 | 98 Thousand GBP | -69.47% |
2008 | 321 Thousand GBP | 154.76% |
2007 | 126 Thousand GBP | 2420.0% |
2006 | 5000.00 GBP | -81.48% |
2005 | 27 Thousand GBP | 0.0% |
2004 | 27 Thousand GBP | 285.71% |
2003 | 7000.00 GBP | -41.67% |
2002 | 12 Thousand GBP | -55.56% |
2001 | 27 Thousand GBP | 125.0% |
2000 | 12 Thousand GBP | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - GBP | 0.0% |
2024 Q1 | - GBP | 0.0% |
2023 Q1 | 3.96 Million GBP | -8.71% |
2023 FY | 3.9 Million GBP | -10.0% |
2023 Q3 | 3.9 Million GBP | -1.41% |
2023 Q4 | 3.9 Million GBP | 0.0% |
2023 Q2 | 3.96 Million GBP | 0.0% |
2022 Q3 | 4.33 Million GBP | -7.13% |
2022 Q2 | 4.67 Million GBP | 0.0% |
2022 Q1 | 4.67 Million GBP | 157.27% |
2022 FY | 4.33 Million GBP | 138.93% |
2022 Q4 | 4.33 Million GBP | 0.0% |
2021 Q2 | 1.92 Million GBP | 0.0% |
2021 Q4 | 1.81 Million GBP | 0.0% |
2021 FY | 1.81 Million GBP | 95.69% |
2021 Q1 | 1.92 Million GBP | 107.54% |
2021 Q3 | 1.81 Million GBP | -5.71% |
2020 Q2 | 1.61 Million GBP | 0.0% |
2020 Q4 | 928 Thousand GBP | 0.0% |
2020 Q3 | 928 Thousand GBP | -42.4% |
2020 FY | 928 Thousand GBP | -22.73% |
2020 Q1 | 1.61 Million GBP | 0.0% |
2019 Q3 | 1.49 Million GBP | 0.0% |
2019 Q1 | - GBP | 0.0% |
2019 FY | 1.2 Million GBP | 0.0% |
2019 Q2 | - GBP | 0.0% |
2018 Q1 | - GBP | 0.0% |
2018 Q3 | - GBP | 0.0% |
2018 FY | - GBP | 0.0% |
2018 Q4 | - GBP | 0.0% |
2017 Q4 | - GBP | 0.0% |
2017 Q3 | - GBP | 0.0% |
2017 Q2 | - GBP | 0.0% |
2017 Q1 | - GBP | 0.0% |
2017 FY | - GBP | 0.0% |
2016 Q2 | - GBP | 0.0% |
2016 Q1 | - GBP | 0.0% |
2016 Q3 | - GBP | 0.0% |
2016 Q4 | - GBP | 0.0% |
2016 FY | - GBP | 0.0% |
2015 FY | - GBP | 0.0% |
2015 Q2 | - GBP | 0.0% |
2015 Q3 | - GBP | 0.0% |
2015 Q4 | - GBP | 0.0% |
2015 Q1 | - GBP | 0.0% |
2014 Q3 | - GBP | 0.0% |
2014 Q4 | - GBP | 0.0% |
2014 FY | - GBP | 0.0% |
2014 Q2 | - GBP | 0.0% |
2014 Q1 | - GBP | 0.0% |
2013 FY | - GBP | -100.0% |
2013 Q2 | 132 Thousand GBP | 0.19% |
2013 Q3 | 132 Thousand GBP | 0.0% |
2013 Q4 | - GBP | -100.0% |
2013 Q1 | 131.75 Thousand GBP | -0.19% |
2012 FY | 131.75 Thousand GBP | 0.57% |
2012 Q4 | 132 Thousand GBP | 0.19% |
2012 Q3 | 131.75 Thousand GBP | 0.0% |
2012 Q2 | 131.75 Thousand GBP | -0.19% |
2012 Q1 | 132 Thousand GBP | 0.0% |
2011 FY | 131 Thousand GBP | -40.99% |
2011 Q3 | 132 Thousand GBP | 0.0% |
2011 Q1 | 222 Thousand GBP | 0.0% |
2010 Q3 | 225 Thousand GBP | 0.0% |
2010 FY | 222 Thousand GBP | 126.53% |
2010 Q1 | 98 Thousand GBP | 0.0% |
2009 Q3 | 288 Thousand GBP | 0.0% |
2009 Q1 | 321 Thousand GBP | 0.0% |
2009 FY | 98 Thousand GBP | -69.47% |
2008 FY | 321 Thousand GBP | 154.76% |
2008 Q3 | 186 Thousand GBP | 0.0% |
2008 Q1 | 126 Thousand GBP | 0.0% |
2007 FY | 126 Thousand GBP | 2420.0% |
2007 Q3 | 72 Thousand GBP | 0.0% |
2007 Q1 | 5000.00 GBP | 0.0% |
2006 Q1 | 27 Thousand GBP | 0.0% |
2006 FY | 5000.00 GBP | -81.48% |
2006 Q3 | 14 Thousand GBP | 0.0% |
2005 Q1 | 1000.00 GBP | 0.0% |
2005 FY | 27 Thousand GBP | 0.0% |
2005 Q3 | 36 Thousand GBP | 0.0% |
2004 Q3 | 2000.00 GBP | 0.0% |
2004 Q1 | 7000.00 GBP | 0.0% |
2004 FY | 27 Thousand GBP | 285.71% |
2003 FY | 7000.00 GBP | -41.67% |
2003 Q3 | - GBP | 0.0% |
2002 FY | 12 Thousand GBP | -55.56% |
2001 FY | 27 Thousand GBP | 125.0% |
2000 FY | 12 Thousand GBP | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Bio Medica Corporation | 6000.00 USD | -64983.333% |
Arrayit Corporation | - USD | -Infinity% |
Atlantic International Corp. | 1.29 Million USD | -200.96% |
Biocept, Inc. | 10.37 Million USD | 62.361% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 51.3 Million USD | 92.389% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 93.622% |
HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -614.777% |
iMD Companies, Inc. | 1.1 Million USD | -253.821% |
IDenta Corp. | 428.17 Thousand USD | -812.008% |
Interpace Biosciences, Inc. | 4.24 Million USD | 7.966% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | - USD | -Infinity% |
Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 278 Thousand USD | -1304.676% |
NovelStem International Corp. | 3.32 Million USD | -17.458% |
Optigenex Inc. | 4.42 Million USD | 11.793% |
PharmChem, Inc. | - USD | -Infinity% |
Proteome Sciences plc | 1.63 Million USD | -139.424% |
Response Genetics, Inc | 4.91 Million USD | 20.598% |
Rennova Health, Inc. | 359.19 Thousand USD | -987.159% |
RushNet, Inc. | 4.25 Million USD | 8.169% |
ScreenPro Security Inc. | 249.05 Thousand USD | -1467.958% |
Stella Diagnostics Inc. | 798.44 Thousand USD | -389.078% |
StageZero Life Sciences Ltd. | 576.38 Thousand USD | -577.502% |
Todos Medical Ltd. | 33 Million USD | 88.167% |